Cargando…

A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer

BACKGROUND: Cancer-associated fibroblasts (CAFs) play an important role in breast cancer pathogenesis by paracrine regulation of breast cancer cell biology. Several in vitro and mouse models have characterized the role of cell contact and cytokine molecules mediating this relationship, although few...

Descripción completa

Detalles Bibliográficos
Autores principales: Hosein, Abdel Nasser, Livingstone, Julie, Buchanan, Marguerite, Reid, James F, Hallett, Michael, Basik, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369836/
https://www.ncbi.nlm.nih.gov/pubmed/25884794
http://dx.doi.org/10.1186/s12885-015-1117-0
_version_ 1782362798011973632
author Hosein, Abdel Nasser
Livingstone, Julie
Buchanan, Marguerite
Reid, James F
Hallett, Michael
Basik, Mark
author_facet Hosein, Abdel Nasser
Livingstone, Julie
Buchanan, Marguerite
Reid, James F
Hallett, Michael
Basik, Mark
author_sort Hosein, Abdel Nasser
collection PubMed
description BACKGROUND: Cancer-associated fibroblasts (CAFs) play an important role in breast cancer pathogenesis by paracrine regulation of breast cancer cell biology. Several in vitro and mouse models have characterized the role of cell contact and cytokine molecules mediating this relationship, although few reports have used human CAFs from breast tumors. METHODS: Primary breast CAF cultures were established and gene expression profiles analysed in order to guide subsequent co-culture models. We used a combination of colorimetric proliferation assays and gene expression profiling to determine the effect of CAFs on the MCF-7 breast cancer cell in an indirect co-culture system. RESULTS: Using gene expression profiling, we found that a subgroup of breast CAFs are positive for a type one interferon response, confirming previous reports of an activated type one interferon response in whole tumor datasets. Interferon positive breast cancer patients show a poor prognostic outcome in an independent microarray dataset. In addition, CAFs positive for the type one interferon response promoted the growth of the MCF-7 breast cancer cell line in an indirect co-culture model. The addition of a neutralizing antibody against the ligand mediating the type one response in fibroblasts, interferon-β, reverted this co-culture phenotype. CAFs not expressing the interferon response genes also promoted the growth of the MCF-7 breast cancer cell line but this phenotype was independent of the type one fibroblast interferon ligand. CONCLUSIONS: Primary breast CAFs show inter-patient molecular heterogeneity as evidenced by interferon response gene elements activated in a subgroup of CAFs, which result in paracrine pro-proliferative effects in a breast cancer cell line co-culture model. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1117-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4369836
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-43698362015-03-24 A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer Hosein, Abdel Nasser Livingstone, Julie Buchanan, Marguerite Reid, James F Hallett, Michael Basik, Mark BMC Cancer Research Article BACKGROUND: Cancer-associated fibroblasts (CAFs) play an important role in breast cancer pathogenesis by paracrine regulation of breast cancer cell biology. Several in vitro and mouse models have characterized the role of cell contact and cytokine molecules mediating this relationship, although few reports have used human CAFs from breast tumors. METHODS: Primary breast CAF cultures were established and gene expression profiles analysed in order to guide subsequent co-culture models. We used a combination of colorimetric proliferation assays and gene expression profiling to determine the effect of CAFs on the MCF-7 breast cancer cell in an indirect co-culture system. RESULTS: Using gene expression profiling, we found that a subgroup of breast CAFs are positive for a type one interferon response, confirming previous reports of an activated type one interferon response in whole tumor datasets. Interferon positive breast cancer patients show a poor prognostic outcome in an independent microarray dataset. In addition, CAFs positive for the type one interferon response promoted the growth of the MCF-7 breast cancer cell line in an indirect co-culture model. The addition of a neutralizing antibody against the ligand mediating the type one response in fibroblasts, interferon-β, reverted this co-culture phenotype. CAFs not expressing the interferon response genes also promoted the growth of the MCF-7 breast cancer cell line but this phenotype was independent of the type one fibroblast interferon ligand. CONCLUSIONS: Primary breast CAFs show inter-patient molecular heterogeneity as evidenced by interferon response gene elements activated in a subgroup of CAFs, which result in paracrine pro-proliferative effects in a breast cancer cell line co-culture model. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12885-015-1117-0) contains supplementary material, which is available to authorized users. BioMed Central 2015-03-15 /pmc/articles/PMC4369836/ /pubmed/25884794 http://dx.doi.org/10.1186/s12885-015-1117-0 Text en © Hosein et al.; licensee BioMed Central. 2015 This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hosein, Abdel Nasser
Livingstone, Julie
Buchanan, Marguerite
Reid, James F
Hallett, Michael
Basik, Mark
A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer
title A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer
title_full A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer
title_fullStr A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer
title_full_unstemmed A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer
title_short A functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer
title_sort functional in vitro model of heterotypic interactions reveals a role for interferon-positive carcinoma associated fibroblasts in breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369836/
https://www.ncbi.nlm.nih.gov/pubmed/25884794
http://dx.doi.org/10.1186/s12885-015-1117-0
work_keys_str_mv AT hoseinabdelnasser afunctionalinvitromodelofheterotypicinteractionsrevealsaroleforinterferonpositivecarcinomaassociatedfibroblastsinbreastcancer
AT livingstonejulie afunctionalinvitromodelofheterotypicinteractionsrevealsaroleforinterferonpositivecarcinomaassociatedfibroblastsinbreastcancer
AT buchananmarguerite afunctionalinvitromodelofheterotypicinteractionsrevealsaroleforinterferonpositivecarcinomaassociatedfibroblastsinbreastcancer
AT reidjamesf afunctionalinvitromodelofheterotypicinteractionsrevealsaroleforinterferonpositivecarcinomaassociatedfibroblastsinbreastcancer
AT hallettmichael afunctionalinvitromodelofheterotypicinteractionsrevealsaroleforinterferonpositivecarcinomaassociatedfibroblastsinbreastcancer
AT basikmark afunctionalinvitromodelofheterotypicinteractionsrevealsaroleforinterferonpositivecarcinomaassociatedfibroblastsinbreastcancer
AT hoseinabdelnasser functionalinvitromodelofheterotypicinteractionsrevealsaroleforinterferonpositivecarcinomaassociatedfibroblastsinbreastcancer
AT livingstonejulie functionalinvitromodelofheterotypicinteractionsrevealsaroleforinterferonpositivecarcinomaassociatedfibroblastsinbreastcancer
AT buchananmarguerite functionalinvitromodelofheterotypicinteractionsrevealsaroleforinterferonpositivecarcinomaassociatedfibroblastsinbreastcancer
AT reidjamesf functionalinvitromodelofheterotypicinteractionsrevealsaroleforinterferonpositivecarcinomaassociatedfibroblastsinbreastcancer
AT hallettmichael functionalinvitromodelofheterotypicinteractionsrevealsaroleforinterferonpositivecarcinomaassociatedfibroblastsinbreastcancer
AT basikmark functionalinvitromodelofheterotypicinteractionsrevealsaroleforinterferonpositivecarcinomaassociatedfibroblastsinbreastcancer